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ABSTRACT  
The  combination  of  simple  Electrochemical  Micro-Paper-based  Analytical  Devices 
(EµPADs)  with  commercially  available  glucometers  allows  rapid,  quantitative 
electrochemical  analysis  of  a  number  of  compounds  relevant  to  human  health  (e.g., 
glucose, cholesterol, lactate, and alcohol) in blood or urine. 
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INTRODUCTION 
This article describes a simple, electroanalytical system ⊯ based on the 
combination of a commercial hand-held glucometer with easily fabricated Micro-Paper-
based Analytical Devices (µPADs) ⊯ that is useful in quantitative analysis of 
metabolites such as glucose, cholesterol, and lactate in human plasma or whole blood, 
and ethanol (or acetaldehyde) in aqueous solution. These electrochemical devices (which 
we call Electrochemical µPADs or EµPADs) provide fluid handling, and support sensing 
electrodes; an inexpensive, commercial electrochemical reader (a glucometer) carries out 
electrochemical analyses and displays the results in digital format. The glucometer is an 
amperometer that is used to measure the quantity of an electroactive species formed by 
the reaction of glucose with reagents stored in the test strips.
1 The EµPADs include 
microfluidic channels, electrodes, and electrical interconnects fabricated in 
chromatography paper using wax printing and screen printing (Figure 1A, B). The wires 
were printed using silver ink, and four electrodes (a working electrode, a counter 
electrode, and two internal reference electrodes) were printed using graphite ink.  
The chemical reagents needed for the assays of glucose and alcohol were stored in 
the detection zone of the EµPAD. To use this system, we usually inserted the dry EµPAD 
into the port of the glucometer. After applying a drop of fluid to the exposed end of the 
EµPAD, and allowing liquid containing the analytes to wick to its sensing region, the 
glucometer initiated amperometric measurement, and displayed the electrochemical 
readout on its LCD screen (Figure 1C). In some reactions (e.g., those for lactate and 
cholesterol), when the time interval required to complete the enzymatic reactions was 
greater than the 10-second waiting-time set in the glucometer, we mixed the solution of    4 
Figure 1. Components of an EµPAD-based system that uses a commercial glucometer as 
an electrochemical reader. A) Arrays of microfluidic paper channels fabricated in 
chromatography paper using wax printing, and an enlarged image of one paper channel 
(left), and a representative microfluidic paper device with electrodes and electronic wires 
fabricated using screen printing (right). The number of devices that could be fabricated 
on one US letter-sized page was approximately 150 - 200. B) A photograph of a 
commercial test strip made from plastic (left), and an EµPAD made from a single layer of 
paper (right); chemical reagents were stored in dry form in the detection zone in the 
dashed square. C) The glucometer used as a reader. An EµPAD was inserted into the test 
port with the contacts and the display facing up. After applying an aqueous solution 
containing analytes, the glucometer displayed the electrochemical readout on its LCD 
screen.   
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Figure 1 
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analytes with the chemical reagents needed for the assays in a small centrifuge tube (the 
mixing can also be conducted on any clean substrate, such as a plastic thin film, or the 
surface of a table), and allowed the reaction to proceed to completion. We then inserted a 
dry EµPAD into the port of the glucometer, and dipped the exposed end of the EµPAD 
into this reacted solution to perform the analysis.  
This work is part of a broad effort to develop high-quality, low-cost biomedical 
analyses appropriate for use in the developing world, and in resource–limited settings.
2-8 
Here we take advantage of a highly developed and commercially successful 
technology—the electrochemical quantification of glucose in blood—for other 
applications. We believe that these electrochemical systems possess the characteristics 
required to be useful in a range of applications, including human, animal and plant 
diagnostics, food-quality control, and environmental monitoring.
9, 10  
The technology used in the currently available glucometer is based on the 
quantitation of electron-transfer mediators (e.g., ferrocyanide) generated by the 
enzyme-catalyzed oxidation of glucose (eq. 1, GOx is glucose oxidase)
1, 11, 12. 
Glucometers are designed to combine specificity based on enzymes, and 
electrochemistry for quantitation. Amperometry makes the device relatively 
insensitive to variations in the catalytic activity of the GOx.
11 
  
 
 
Our objective here is to demonstrate that glucometers have the combination of 
characteristics needed in a broad range of assays in resource-limited environments. We 
(1)   7 
take the advantage of three facts: i) The market for blood testing devices is sufficiently 
large that the costs for development of this successful and robust technology have already 
been absorbed. ii) These electrochemical devices integrate smoothly with Micro-Paper-
based Analytical Devices (µPADs)
6, 13 that we are developing, and can thus be adapted to 
analyze a broad range of analytes. iii) The output of these systems can be read directly, or 
coupled to cell phones, for telemedicine-based applications.  
EµPADs. We
14 and others
15-17 have recently developed microfluidic paper-
based electrochemical devices capable of quantitative analysis of a range of 
substances (e.g. glucose, enzymes, serum proteins, and heavy metal ions) in aqueous 
solutions. Although electrochemistry provides an enormously powerful set of 
analytical methods, electrochemical systems of the types used in research, industrial, 
and clinical laboratories are too expensive and cumbersome to be practical for use in 
resource-limited environments. Glucometers provide, we believe, a way to bridge the 
gap between laboratory use and field use of electrochemistry.  
Commercially available electrochemical glucose test strips are typically made on 
a plastic substrate, and their price (including, of course, margin) in the U.S. — ~$0.5-
1.0/strip
1,18 — is impractically high for applications in the developing world. Test strips 
that would be produced at lower cost, and that would assay analytes other than glucose, 
might fit a range of uses. Glucose testing for diabetes control is currently the dominant 
application of glucometers, but we believe that this technology can be extended to a large 
group of substances other than glucose.   
The electrochemical analytical system described in this article has at least five 
advantages: i) It offers a simple, fast (<60 s for detection, for systems that develop most   8 
rapidly), and low-cost (at current stage of development, ~$0.014/strip for the materials 
and use of equipment 
19 for a glucose test). There are clear opportunities to lower this 
cost further, and to fabricate a glucometer for substantially less than $10. ii) The strips 
are light-weight, portable, rugged, and safely disposable by incineration.
20  iii) It does not 
require professional medical personnel or complicated instruments. iv) The same reader 
can be adapted to a range of different analytes. v) Electrochemical methods are 
insensitive to light, dust, and insoluble particulates, and are thus applicable to dirty 
environments, and to samples containing suspended solids (where optical methods might 
fail).  This system has three disadvantages: i) It requires batteries (one 3-V lithium 
battery is capable of carrying out approximately 1100 measurements). ii) Its assays are 
susceptible to interferences from electrochemically active substances. iii) Certain assays 
may be sensitive to temperature.  
EXPERIMENTAL DESIGN 
Fabrication of the Devices. We fabricated paper-based microfluidic channels by 
patterning chromatographic paper (Whatman 1 Chr) by wax printing, as described 
previously.
21 We screen-printed wires and contact pads using silver ink, and four 
electrodes from graphite ink, on a piece of patterned paper.
10 The external circuits do not 
contact the solution of analytes being measured, and less expensive conducting inks (e.g., 
copper or aluminum ink) could be used to lower the cost of the test strips further.  
Glucometers. We chose the True Track
TM blood glucometer
22(CVS/Pharmacy) as 
the electrochemical reader. This glucometer has two attractive characteristics: i) Its cost 
is low (the meter retails for about $20 for each; it is, however, usually supplied free with 
the test strips), and it is simple to use. ii) It is easy to reverse engineer the format used in   9 
its test strips into a format that fits our needs. Other glucometers could, however, also be 
used. The design required differs with the test: one that requires concentration ⊯ for 
example, for the analysis of water ⊯ might be different from one that works with blood, 
and one that required removing cells from  blood by filtration might be different from the 
one used with whole blood or urine.  
Since commercial test strips may vary from batch to batch, this model of 
glucometer requires the user to enter a code on a code chip that comes with the test 
strips. Inserting the code chip into the glucometer calibrates it for that batch of test 
strips (Figure SI2). We have not tried to replicate this level of calibration in our 
present work. 
Design of Paper-based Electrochemical Devices. We designed the EµPADs to 
fit into the port of the glucometer. We fabricated the circuits of the EµPAD to mimic the 
format of the test strips sold for this device. We treated the detection zones of the EµPAD 
with a solution of 2 wt% 3-aminopropyldimethyl-ethoxysilane (APDES) in water to 
enhance the hydrophilicity of the paper channels, and of the electrodes.
23,24   
Methods and Principles of Detection. We measured concentrations of D-
glucose, cholesterol, L-lactate, and ethanol on the EµPADs using amperometry, utilizing 
the glucometer as an electrochemical reader. Eq. 2 generalizes the reactions for the 
amperometric detection of D-glucose, cholesterol, and L-lactate 
1, 10, 12, 25.  
  
 
 
(2)   10 
In the enzyme-catalyzed step, glucose oxidase (GOx), or another oxidase, catalyzed the 
oxidation of glucose (or cholesterol or lactate) to gluconic acid (or cholest-4-en-3-one or 
pyruvate) with concomitant reduction of Fe(III) to Fe(II) (eq. 2); The Fe(II)(CN)6
4- ions 
generated were detected amperometrically.      
Eq. 3 and 4 describe the mechanism of enzymatic detection of ethanol in the 
presence of β-NAD
+10. The oxidation of ethanol to acetaldehyde in a reaction catalyzed 
by alcohol dehydrogenase reduced β-NAD
+ to NADH (eq. 3). The electron-transfer 
mediator ferricyanide, present in the solution, rapidly oxidized the NADH to β-NAD
+ 
with concomitant reduction of Fe(III) to Fe(II) (eq. 4); the Fe(II)(CN)6
4- ions generated 
were detected amperometrically.  
          
                                                                              
 
 
RESULTS AND DISCUSSION 
Optimization of the Design of EµPAD 
We used EµPADs made from a single layer of paper (rather than two or more 
layers, although multilayer designs may be useful, or even required, in some complex 
assays). These EµPADs incorporated channels patterned with hydrophobic walls to 
control the flow of liquids and to support the electrochemical measurements (Figure 
1A, B). A single-layer platform has at least three advantages: i) It allows reproducible 
conformal contact between the electrodes and the paper channels. ii) Its fabrication 
(3) 
(4)   11 
can be scaled to large numbers (10
3-4 strips/day by hand or 10
7-8 strips/day by 
machine). iii) It requires a smaller quantity of solution of analytes than multilayer 
devices. 
It was important to treat the detection zone of the EµPADs with APDES or 
another agent that enhanced wetting, in order to: i) increase the hydrophilicity of the 
surface of the graphite electrodes, and thus the effective area of contact of the 
electrode surface with the solution of analytes (Figure SI3), and ii) increase the rate of 
wicking of the solution of analytes in the paper channel. If the rate of mass transport 
of fluids is not sufficiently rapid to deliver the fluids to wet all electrodes, the 
glucometer displays an error message. 
Evaluation of the Meter for the Use in EµPAD 
In order to fit the capability of the glucometer to our electrode geometry, we 
adjusted the dimensions of the electrodes of the EµPAD to make the measured currents 
fit the desired range of concentrations.
26 Based on the Cottrell equation, the electrical 
current, i, of the system is linearly proportional to the surface area, A, of electrode 
(i∝A).
27 In principle, the same objective might be achieved by reprogramming the code 
chip that comes with the glucometer; but to do so would require more understanding of 
the design, circuiting, and control of the device than we have.  
To evaluate the compatibility of the commercial glucometers with our EµPADs, 
we generated a calibration curve for the measurement of glucose in human plasma 
(Figure 2). The value of glucose concentration displayed by the glucometer increased 
linearly with the concentration of glucose, [glucose]; the slope of this plot was 1.09 
units/(mg⋅dL
-1) (intercept, 17.0, correlation coefficient, 0.993). The analysis of glucose    12 
Figure 2. Calibration plots for the analysis of glucose in human plasma in commercial 
test strips (ﾙ) and in EµPADs (ﾘ) made from a single layer of paper, using a 
commercial glucometer. The solid lines represent linear fits to experimental data with 
regression equations: y=-2.9+1.05x (R
2 = 0.997, n=7) (ﾙ), and y=17.0+1.09x (R
2 = 
0.993, n=7) (ﾘ). Inset shows the readings of glucose concentration in EµPADs plotted as 
a function of glucose concentration measured by commercial test strips. The solid line in 
the inset represents a linear fit to experimental data with a regression equation: 
y=11.9+1.05x (R
2 = 0.995, n=7). [Glucose]paper: the displayed concentration of glucose in 
EµPADs. [Glucose]commercial: the displayed concentration of glucose in commercial test 
strips. 
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in human plasma in commercial plastic-based test strips produced a similar linear 
calibration curve with a slope of 1.05 unit/(mg⋅dL
-1) (intercept, -2.9, correlation 
coefficient, 0.997) (Figure 2).  
The range of linear concentrations in EµPADs (from 0 to 500 mg/dL) covers 
the medically relevant range of glucose concentrations (~ 70-120 mg/dL).
1 A wider 
linear range of concentrations ⊯ for use, for example, in food testing ⊯ could be 
achieved by optimizing the geometry of the device and the surface area of working 
electrode, although the precision of the device might suffer. 
Table 1 summarizes the comparison between the performance of the analysis 
of glucose in EµPADs with that in commercial test strips. The limit of detection (LOD) 
was calculated as the concentrations which produced three times SD0, where SD0 is 
the value of the standard deviation as the concentration of the analyte approaches zero. 
The lower LOD of 26 mg/dL glucose obtained using EµPADs is slightly larger than 
the LOD of 15 mg/dL glucose achieved with commercial test strips. The mean 
coefficient of variation in these analyses in EµPADs was 9.1%. This value is 
approximately twice the 4.1% of the commercial glucose test strips.
22 We attribute the 
higher value of this coefficient of variation in EµPADs to variations in the width of 
paper channels fabricated by wax printing, and to variations in the width of electrodes 
fabricated by screen printing; the reproducibility of measurements in our system 
could certainly be increased by improved engineering and standardized fabrication. 
The minimum volume of samples required to wet the paper channel completely 
was approximately 1.0 µL for the design of the EµPAD used for this specific assay; this 
quantity can be decreased further by shortening the length of paper channel, or by using a    15 
Table 1. Comparison of the Performance of EµPADs with Commercial Plastic-based 
Glucose Test Strips. 
Substrate  Linear 
dynamic 
range 
(mg/dL) 
Limit of 
detection 
(mg/dL) 
Mean 
coefficient of 
variation 
(%)
b 
Minimum 
volume of 
sample (µL) 
Test for 
blood 
samples 
(mg/dL)
c 
Commercial 
test strips 
~0 − 550
a  ~26  4.1  ~1.0  99±3
d 
Paper strips  ~0 − 500  ~15  9.1  ~1.0  95±9
e 
a The linear dynamic range reported previously was 0 − 600 mg/dL.
22 
b The mean 
coefficient of variation was calculated by averaging relative standard deviations of the 
measurements of standard solutions with glucose concentration of 25, 50, 100, 150, 200, 
300, 400, and 500 mg/dL. 
c For the analysis of blood samples with unknown 
concentration of glucose, a small drop of blood was obtained by pricking the skin with a 
steel lancet  
d Three measurements were averaged. 
e Eight measurements were averaged.  
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thinner paper. This EµPAD is probably sensitive to temperature, due to rates of 
evaporation and wicking of solutions.   
We compared the analysis of glucose in human whole blood using EµPADs with 
commercial test strips. We brought the inlet of an EµPAD into contact with a small 
droplet of blood obtained from a fingerprick. The blood, containing blood cells, rapidly 
filled the paper channel by wicking (this way does not require the paper to remove cells), 
and the glucometer initiated the electrochemical measurement, and displayed the result of 
measurement. The levels of glucose in whole blood are generally 10-15% lower than 
glucose in plasma;
28 and the concentrations of glucose in blood, [Glucose]blood, can be 
approximated to the measured values of plasma glucose, [Glucose]plasma 
([Glucose]blood=[Glucose]plasma/1.14).
29 The calibration curves for the analysis of glucose 
in human plasma (Figure 2) were therefore, used to determine the concentration of 
glucose in blood. The corrected concentration of glucose in blood was 95 ± 9 mg/dL 
(n=8) measured in EµPADs; this value was about 4.4% lower than the value 99 ± 3 
mg/dL (n=3) obtained in commercial test strips.  
We conclude that ⊯ at this stage of the work (laboratory prototype) ⊯ the 
performance of the EµPADs is roughly equivalent to that of commercial test strips. 
Since we are using the same chemistry as that used commercially, the agreement is 
not surprising. It does, however, validate EµPADs as electrochemical sensors for use 
⊯ in conjunction with commercial glucometers ⊯ in biomedical sensing. 
Applications in Analyzes Other Than Glucose 
We evaluated the feasibility of using EµPADs and this glucometer to measure   17 
the concentration of analytes other than glucose. We demonstrated the analysis of 
cholesterol and L-lactate in human plasma as well as ethanol in aqueous solutions.  
Clinical Diagnostics: Analysis of Cholesterol and L-Lactate in Body Fluids 
The concentration of cholesterol in human plasma is less than 5.2 mM (200 mg/dL).
30 
The analysis of cholesterol in human plasma using cholesterol oxidase yielded a 
linear calibration plot in the concentrations ranging from 20-200 mg/dL (0.5-
5.2mM);
31 these values cover the clinically relevant range of cholesterol 
concentrations (Figure 3A).
30 The limit of detection was 13 mg/dL (0.34 mM), and 
the sensitivity was approximately 0.8 unit/(mg·dL
-1). The mean coefficient of 
variation of these analyses was about 6.2% (n=7). 
The clinically relevant range of L-lactate concentrations is from 0.5 to 15-20 
mM in serum or plasma.
32, 33 Commercial lactate meters have a range of 0.8−23.3 mM 
with a 60 s sampling time, and require 5 µL of sample. We demonstrated the use of 
the glucometer to analyze the concentration of L-lactate in human plasma. The 
calibration curve for the measurement of L-lactate shows that the values displayed are 
linearly proportional to the L-lactate concentrations in the range of 1-11 mM with a 
sensitivity of 2.8 units/(mg·dL
-1) (~ 25.5 units/mM) (Figure 3B). The concentration 
range for quantitative detection is, therefore, slightly narrower than the clinically 
relevant range at this stage of development of EµPADs. The reliable lower limit of 
detection was 9.8 mg/dL (~1.1 mM).
34 Both assays of cholesterol and L-lactate on 
these specific EµPADs require approximately 1.2-1.5 µL of fluid; this value is 
determined by the quantity required to wet the paper channels completely.  
Although it would be straightforward to tune the geometry of EµPADs to    18 
Figure 3. Application of glucometers as electrochemical readers for measuring the 
concentrations of cholesterol and L-lactate in human plasma. Calibration plots for the 
analysis of cholesterol (A) and L-lactate (B) in EµPADs. The solid lines represent linear 
fits to experimental data with regression equations: (A) y=90.1+0.8x (R
2=0.962, n=7), 
and (B) y=236.7+2.8x (R
2=0.989, n=7). 
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Figure 3 
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adjust the displayed values closer to actual concentrations of analytes, we have not 
done so for the cholesterol and L-lactate systems in the same way as we did for the 
glucose system. It would also be possible to use a chip to adjust for the response 
produced by our EµPADs, since different batches of commercial test strips are 
accompanied with individual calibration codes embeded in code chips. 
We note that the glucometer displays a non-zero value in the analysis of 
sample solutions in the absence of analytes (Figure 3). We attribute this value to 
background contributions due to the charging process of the electrical double layer, 
and to the redox reactions of ferrocyanide generated by the degradation of a small 
fraction of ferricyanide in solutions (even if the solution of electron-transfer 
mediators is freshly prepared).
35 This measured value could, however, be calibrated to 
display an actual concentration of analytes.  
Food Quality Control:  Analysis of Alcohol in Water The electrochemical 
system has the potential to be useful in food quality control. We used EµPADs and 
glucometer to measure the concentration of ethanol. The calibration plot for the 
analysis of ethanol (Figure 4A, B) showed a linear range from 0.1 to 3 mM 
(R
2=0.970) with a sensitivity of 54 units/mM. The limit of detection was 0.1 mM, and 
the coefficient of variation ranged from 3.2% to 10.1%. 
Table 2 summarizes the performance of this electrochemical system for these 
analyses. The linear ranges of detection as well as the limit of detection achieved in 
EµPADs cover useful ranges, but leave substantial room for engineering 
improvement.  
CONCLUSIONS   21 
The EµPADs are compatible with commercially available glucometers.  The 
use of glucometers as readers for EµPADs substantially increases the range of options 
for combining paper–based analytical devices and electrochemical detection for 
applications in resource-constrained environments. This electrochemical system has 
six potential advantages: i) It is portable, reliable, and inexpensive. ii) It takes 
advantage of the sophisticated engineering already embedded in commercially 
available, inexpensive glucometers. iii) It can be adapted to analytes other than 
glucose. iv) Electrochemistry ⊯ unlike colorimetry and spectrophotometry ⊯  is 
insensitive to local light conditions, and to certain types of contaminants (suspended 
solids, colored materials) present in samples. v) It can be interfaced with a cell phone 
(either by human reporting of the data, by photography the LCD display, or, in 
principle by a coded interface). It can also be used in home patient care with 
telephone or internet communications.
13 vi) It can also, in principle, be adapted to a 
range of different types of assays (amperometry, as here; chronoamperometry, cyclic 
voltammetry, annodic stripping voltammetry, electrochemiluminescence, and others).   
The EµPAD has at least five useful characteristics for applications in resource-
limited envrionments (no plastic strips have all of these characterstics): i) It is well 
suited to mass-production at low cost using wax-printing and screen-printing 
technologies. It can, therefore, be manufactured almost everywhere, and easily 
adapted to local use. ii) It can be used in analyses of complex fluids (e.g., blood, 
urine, and saliva), even when they contain suspended solids and dirt.. iii) Its 
fundamental design is sufficiently simple that this design can be modified to generate 
test strips that fit into different types of glucometers, or that carry out different    22 
Figure 4. Glucometers as electrochemical readers for the analysis of ethanol. (A) 
Calibration plot for the analysis of ethanol in aqueous solutions, and (B) an enlarged 
graph in the dashed square in (A). The solid line in (B) represents a linear fit to 
experimental data with a regression equation: y=139.4+53.9x (R
2=0.970, n=7). 
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Figure 4 
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Table 2. Glucometers as Electrochemical Readers for Amperometric Detection in 
EµPADs. 
Analyte  Enzyme  Electron-
transfer 
mediator 
Dynamic 
linear range 
Limit of 
detection 
Notes 
Glucose  Glucose oxidase  ferricyanide  0-500 
mg/dL 
26 mg/dL  pre-stored
a 
Ethanol  Alcohol 
dehydrogenase/β-
NAD
+  
ferricyanide  0.1-3 mM   0.2 mM  pre-stored 
Cholesterol  Cholesterol 
oxidase 
ferricyanide  20-200 
mg/dL 
13 mg/dL  pre-mixed
b 
L-lactate  Lactate oxidase      ferricyanide  1.1-11 mM     1.1 mM
c  pre-mixed 
a Pre-stored: we stored chemical reagents needed for the assay on the EµPAD, and carry 
out the assay with the EµPAD in glucometer. 
b Pre-mixed: we mixed chemical reagents 
needed for the assay with a solution containing analytes, and allowed the reaction to 
proceed to completion off the EµPAD. The glucometer was used simply as an 
amperometer to read the result. 
c The commercially available human plasma itself 
contains 1.1 mM lactate before the addition of any lactate. In fact, we were able to detect 
0.5 mM of lactate in PBS buffer solution (pH 7.0). 
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analytes. iv) It is based on a system of paper-based microfluidic devices of rapidly 
increasing sophistication. The programming of flows of fluids in these devices makes 
it possible to to carry out analysis requiring multiple steps, without using extra 
instruments such as pumps.
36 v) It has sufficient flexibility to incorporate a variety of 
different functionalities ⊯ concentration of analytes by evaporative heating, and 
chromotograpic separation of analytes from interference ⊯ while retaining the 
interface to the glucometer.  
At this stage of development, the EµPADs that we have fabricated are slightly 
less accurate than commercial test strips, possibly due to the manual procedures we 
used in their fabrication; this accuracy will certainly improve with futher engineering 
and attention to manufacturing detail.  
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